428 related articles for article (PubMed ID: 15795937)
1. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
[TBL] [Abstract][Full Text] [Related]
2. SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.
Puolakkainen PA; Bradshaw AD; Brekken RA; Reed MJ; Kyriakides T; Funk SE; Gooden MD; Vernon RB; Wight TN; Bornstein P; Sage EH
J Histochem Cytochem; 2005 May; 53(5):571-81. PubMed ID: 15872050
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors.
Reed MJ; Vernon RB; Abrass IB; Sage EH
J Cell Physiol; 1994 Jan; 158(1):169-79. PubMed ID: 8263022
[TBL] [Abstract][Full Text] [Related]
4. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
5. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
6. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
[TBL] [Abstract][Full Text] [Related]
7. Altered tissue repair in hevin-null mice: inhibition of fibroblast migration by a matricellular SPARC homolog.
Sullivan MM; Puolakkainen PA; Barker TH; Funk SE; Sage EH
Wound Repair Regen; 2008; 16(2):310-9. PubMed ID: 18318815
[TBL] [Abstract][Full Text] [Related]
8. Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice.
Bradshaw AD; Reed MJ; Carbon JG; Pinney E; Brekken RA; Sage EH
Wound Repair Regen; 2001; 9(6):522-30. PubMed ID: 11896995
[TBL] [Abstract][Full Text] [Related]
9. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
[TBL] [Abstract][Full Text] [Related]
10. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
11. SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery.
Seet LF; Su R; Barathi VA; Lee WS; Poh R; Heng YM; Manser E; Vithana EN; Aung T; Weaver M; Sage EH; Wong TT
PLoS One; 2010 Feb; 5(2):e9415. PubMed ID: 20195533
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
[TBL] [Abstract][Full Text] [Related]
13. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
14. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging.
Bach MH; Sadoun E; Reed MJ
Mech Ageing Dev; 2005 Apr; 126(4):467-73. PubMed ID: 15722105
[TBL] [Abstract][Full Text] [Related]
15. Delayed angiogenesis in aging rats and therapeutic effect of adenoviral gene transfer of VEGF.
Wang H; Keiser JA; Olszewski B; Rosebury W; Robertson A; Kovesdi I; Gordon D
Int J Mol Med; 2004 Apr; 13(4):581-7. PubMed ID: 15010860
[TBL] [Abstract][Full Text] [Related]
16. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
Weaver MS; Sage EH; Yan Q
J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
[TBL] [Abstract][Full Text] [Related]
17. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
[TBL] [Abstract][Full Text] [Related]
18. Induction of SPARC by VEGF in human vascular endothelial cells.
Kato Y; Lewalle JM; Baba Y; Tsukuda M; Sakai N; Baba M; Kobayashi K; Koshika S; Nagashima Y; Frankenne F; Noël A; Foidart JM; Hata RI
Biochem Biophys Res Commun; 2001 Sep; 287(2):422-6. PubMed ID: 11554745
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture.
Shiba H; Fujita T; Doi N; Nakamura S; Nakanishi K; Takemoto T; Hino T; Noshiro M; Kawamoto T; Kurihara H; Kato Y
J Cell Physiol; 1998 Feb; 174(2):194-205. PubMed ID: 9428806
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of diabetic nephropathy in SPARC-null mice.
Taneda S; Pippin JW; Sage EH; Hudkins KL; Takeuchi Y; Couser WG; Alpers CE
J Am Soc Nephrol; 2003 Apr; 14(4):968-80. PubMed ID: 12660331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
